Status: current, Defined. Date: 30-Apr 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2693471000168113 | Fluticasone plus Salmeterol 250/25 (Cipla) (fluticasone propionate 250 microgram / 1 actuation + salmeterol 25 microgram / 1 actuation) inhalation, actuation (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2693481000168111 | Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, actuation | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, actuation | has manufactured dose form | inhalation | true | Inferred relationship | Some | ||
| Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, actuation | Is a | fluticasone propionate 250 microgram/actuation + salmeterol 25 microgram/actuation inhalation, actuation | true | Inferred relationship | Some | ||
| Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, actuation | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, actuation | Is a | Fluticasone plus Salmeterol 250/25 (Cipla) | true | Inferred relationship | Some | ||
| Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, actuation | has manufactured dose form | pressurised inhalation | false | Inferred relationship | Some | ||
| Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, actuation | has unit of use | actuation | true | Inferred relationship | Some | 865975829 | |
| Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, actuation | has intended active ingredient | salmeterol | true | Inferred relationship | Some | 357022644 | |
| Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, actuation | has Australian BoSS | salmeterol | true | Inferred relationship | Some | 357022644 | |
| Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, actuation | has intended active ingredient | fluticasone propionate | true | Inferred relationship | Some | 865975828 | |
| Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, actuation | has Australian BoSS | fluticasone propionate | true | Inferred relationship | Some | 865975828 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, 120 actuations | has TPUU | True | Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, actuation | Inferred relationship | Some | 1 |
| Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, 120 actuations, aerosol can | has TPUU | True | Fluticasone plus Salmeterol 250/25 (Cipla) inhalation, actuation | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR